Nations Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$853K Sell
6,753
-75
-1% -$9.88K 0.04% 418
2026
Q1
$952K Buy
6,828
+158
+2% +$22.1K 0.05% 381
2025
Q4
$819K Buy
6,670
+58
+0.9% +$7.05K 0.04% 405
2025
Q3
$734K Buy
6,612
+16
+0.2% +$1.82K 0.05% 405
2025
Q2
$731K Buy
6,596
+401
+6% +$42.7K 0.05% 368
2025
Q1
$694K Sell
6,195
-2,135
-26% -$220K 0.05% 352
2024
Q4
$769K Sell
8,330
-117
-1% -$10.5K 0.06% 332
2024
Q3
$708K Buy
8,447
+2,813
+50% +$215K 0.05% 355
2024
Q2
$387K Buy
5,634
+559
+11% +$37.3K 0.03% 479
2024
Q1
$372K Buy
5,075
+9
+0.2% +$692 0.03% 489
2023
Q4
$410K Sell
5,066
-62
-1% -$4.83K 0.04% 433
2023
Q3
$384K Sell
5,128
-1,002
-16% -$77.1K 0.04% 428
2023
Q2
$472K Buy
6,130
+368
+6% +$29.4K 0.05% 399
2023
Q1
$478K Buy
5,762
+261
+5% +$21.6K 0.05% 379
2022
Q4
$472K Buy
5,501
+2,068
+60% +$164K 0.05% 373
2022
Q3
$212K Sell
3,433
-145
-4% -$9.14K 0.03% 482
2022
Q2
$221K Sell
3,578
-618
-15% -$38.3K 0.03% 466
2022
Q1
$249K Buy
4,196
+1,091
+35% +$69.7K 0.03% 459
2021
Q4
$225K Sell
3,105
-175
-5% -$12.1K 0.03% 445
2021
Q3
$229K Sell
3,280
-605
-16% -$42.5K 0.03% 406
2021
Q2
$268K Buy
3,885
+726
+23% +$48.5K 0.04% 349
2021
Q1
$204K Buy
+3,159
New +$204K 0.05% 333
2020
Q4
Sell
-3,788
Closed -$239K 318
2020
Q3
$239K Sell
3,788
-298
-7% -$20.7K 0.07% 255
2020
Q2
$314K Sell
4,086
-4,055
-50% -$311K 0.11% 207
2020
Q1
$609K Sell
8,141
-4,361
-35% -$301K 0.26% 124
2019
Q4
$812K Buy
12,502
+202
+2% +$13.2K 0.28% 112
2019
Q3
$784K Buy
12,300
+7,928
+181% +$518K 0.28% 110
2019
Q2
$295K Buy
4,372
+274
+7% +$18K 0.2% 135
2019
Q1
$266K Buy
4,098
+273
+7% +$18.1K 0.18% 139
2018
Q4
$239K Buy
3,825
+149
+4% +$10.4K 0.19% 131
2018
Q3
$284K Buy
3,676
+26
+0.7% +$1.96K 0.2% 126
2018
Q2
$259K Hold
3,650
0.22% 131
2018
Q1
$275K Buy
3,650
+700
+24% +$55.6K 0.25% 115
2017
Q4
$211K Sell
2,950
-100
-3% -$7.59K 0.19% 139
2017
Q3
$247K Hold
3,050
0.24% 126
2017
Q2
$216K Hold
3,050
0.18% 158
2017
Q1
$207K Sell
3,050
-155
-5% -$10.9K 0.2% 140
2016
Q4
$230K Sell
3,205
-369
-10% -$27.4K 0.25% 126
2016
Q3
$283K Buy
3,574
+788
+28% +$64K 0.28% 111
2016
Q2
$232K Buy
+2,786
New +$247K 0.24% 133

Other funds holding GILD

Nations Financial Group's GILD Position: Q2 2026 in Review

Nations Financial Group reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $9.88K and leaving 6,753 shares worth $853K. The position accounts for 0.04% of the portfolio, ranked #418.

Nations Financial Group first reported a position in GILD in Q2 2016 and has held it in 40 quarters since. The position peaked at $952K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nations Financial Group held 6,753 shares of Gilead Sciences worth $853K as of Q2 2026.
  • Nations Financial Group sold 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
  • Gilead Sciences made up 0.04% of Nations Financial Group's portfolio in Q2 2026, its #418 holding.
  • Nations Financial Group first reported a position in Gilead Sciences in Q2 2016 and has held it in 40 quarters since.
  • Nations Financial Group's Gilead Sciences position peaked at $952K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.